International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors
about
Adjuvant treatment of anaplastic oligodendrogliomas and oligoastrocytomasClinical management of grade III oligodendrogliomaMolecular Markers in Low-Grade Glioma-Toward Tumor ReclassificationRecursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumorsInitial treatment patterns over time for anaplastic oligodendroglial tumors.Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.Fotemustine: a third-generation nitrosourea for the treatment of recurrent malignant gliomas.Clinical prognostic factors of adjuvant radiation therapy for low-grade gliomas: results of 10 years survivalThe future of high-grade glioma: Where we are and where are we going.Detection of 1p19q deletion by real-time comparative quantitative PCR.Deferred radiotherapy and upfront procarbazine-ACNU-vincristine administration for 1p19q codeleted oligodendroglial tumors are associated with favorable outcome without compromising patient performance, regardless of WHO grade.Prognostic value and their clinical implication of 89-gene signature in gliomaThe impact of chemotherapy on cognitive outcomes in adults with primary brain tumors.Cranial and spinal oligodendrogliomatosis: a case report and review of the literature.Pharmacologic therapies for malignant glioma: a guide for clinicians.Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide.Anaplastic glioma: current treatment and management.Diagnostic, prognostic and predictive relevance of molecular markers in gliomas.Procarbazine, lomustine and vincristine or temozolomide: which is the better regimen?The Role of Molecular Diagnostics in the Management of Patients with Gliomas.Determining optimal treatment strategy for diffuse glioma: the emerging role of IDH mutations.Anaplastic glioma.Anaplastic oligodendroglioma: a new treatment paradigm and current controversies.PCV for anaplastic oligodendrogliomas: back to the future or a step backwards? A point/counterpoint discussion.Anaplastic oligodendroglioma: advances and treatment options.Biomarkers classification and therapeutic decision-making for malignant gliomas.Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers.A multicenter study of anaplastic oligodendroglioma: the Korean Radiation Oncology Group Study 13-12.Moving toward molecular classification of diffuse gliomas in adults.Hypoxia-inducible factor-1-regulated protein expression and oligodendroglioma patient outcome: comparison with established biomarkers and preoperative UCSF low-grade scoring system.Neuro-oncology: anaplastic oligodendrogliomas-value of early chemotherapy.Response to Weltman and Fleury Malheiros, re Lassman et al.Treatment Recommendations for Adult Patients with Diffuse Gliomas of Grades II and III According to the New WHO Classification in 2016.Modulated Radiotherapy with Concurrent and Adjuvant Temozolomide for Anaplastic Gliomas: Indian Single-center Data.SEOM clinical guidelines for anaplastic gliomas (2017).Upfront chemotherapy and subsequent resection for molecularly defined gliomas.Success at last: a molecular factor that informs treatment.Long-term impact of temozolomide on 1p/19q-codeleted low-grade glioma growth kinetics.Pattern of care of anaplastic oligodendroglioma and oligoastrocytoma in a Korean population: the Korean Radiation Oncology Group study 13-12.Current therapeutic approaches to diffuse grade II and III gliomas.
P2860
Q24194645-4580EB64-CF0F-449C-BD19-E86392FC81C1Q26801254-15C66BF2-220F-48A6-8BF9-AECE53A770F8Q28383205-60EDBA34-67AA-4A79-B4FB-DE7F941F3FC3Q30370204-97C9175D-491B-4624-B937-23C935404C6EQ30419123-B19A4158-B3E9-40D1-AD8D-9E363433E184Q30542081-A3238480-C5FA-4000-BC59-E6F4F543E7A2Q33411366-5CB7625B-26A5-494E-B2D3-E37049FBBFB3Q33815954-9780EFA6-918F-43FF-A52D-384323251815Q35114090-93AE9EB2-1023-413F-9962-D169194E8697Q35789635-A5ECF32A-C677-4299-8C11-E17B98834767Q37429161-D35E90E5-7241-409E-981A-803A3378121CQ37588272-AF5974F3-0DBB-47E3-BF7D-964D6B7DA693Q37986511-B4483A22-F4E9-4203-B378-B4E326F53542Q38243100-11A6D360-54BB-4503-8DEE-FE8BC6D44E1FQ38268897-BB1AED31-1A8D-43ED-A5E6-08760389D2BAQ38390616-FA7C3929-CABA-4BDF-BBC2-9E16AB8971A1Q38456018-3FC3A101-4271-4402-8946-CCDC98BC2F2FQ38461565-8CE40B7D-7877-40C5-8854-6EA987C82021Q38626948-099B2A70-E942-4F53-B38E-CA409265C433Q38921975-736AAC31-4550-4A99-8955-68A1325AB409Q39005975-458B0D2A-D393-4260-8289-5273B555F192Q39246821-D09007C8-3D71-46EB-B539-DEE55418CA3EQ39373950-D7323758-8CA7-40D5-B4EC-E708DD0363C1Q39453835-C85894E2-DAE2-403B-8226-8A124985D16EQ39480039-A61CE73D-9FE0-4122-84B1-7E5EFE7FC580Q39556985-D516E705-73D8-443A-96F2-D5BC80404AE6Q40008535-16E5864E-1202-4984-A636-6246D5B151C3Q40572125-1D4F40C6-9DA2-40DE-B27F-655AEEC4E996Q41890894-49F3CCA1-92BF-48AB-9DD4-344F725DA7F8Q43619655-4814B8A8-F22C-459E-B814-A60E2C77E295Q43733606-B07B98B5-5F50-480A-8016-48B494E265E6Q45975426-50159336-1692-453C-95BB-E5E0D97E1FD9Q47133444-4CF0A891-4716-4DC8-A290-DB9D78956AC1Q47732901-B0E8C2AF-921E-44A9-AC06-8824D4660944Q48147847-ECFDBE4D-B571-45DE-97A3-245B83FBAB94Q48160976-8BE70EA6-16EA-47AD-AE33-3D8D1A6BF316Q48250296-16A71B09-C6EE-4D1D-9D36-9AC67D0D8F9BQ48295109-A2885FE1-5C96-470A-90ED-861CCBFB1B25Q48457980-8A790655-2B65-4835-8697-AC5079D17ADAQ49317056-841589DF-A8E1-4EC0-A6A7-9F2E25EA52AC
P2860
International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
International retrospective st ...... lastic oligodendroglial tumors
@ast
International retrospective st ...... lastic oligodendroglial tumors
@en
type
label
International retrospective st ...... lastic oligodendroglial tumors
@ast
International retrospective st ...... lastic oligodendroglial tumors
@en
prefLabel
International retrospective st ...... lastic oligodendroglial tumors
@ast
International retrospective st ...... lastic oligodendroglial tumors
@en
P2093
P2860
P356
P1433
P1476
International retrospective st ...... lastic oligodendroglial tumors
@en
P2093
Andreana L Rivera
Andrew B Lassman
April F Eichler
Barbara J Fisher
Brandon G Rocque
David N Louis
David Schiff
Fabio M Iwamoto
Gloria B Roldán
H Ian Robins
P2860
P304
P356
10.1093/NEUONC/NOR040
P577
2011-06-01T00:00:00Z